GCP
CASC

GSA Capital Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History

GSA Capital Partners’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,950
Closed -$49K – 2094
2016
Q3 		$49K Buy
+4,950
New +$49K ﹤0.01% 1727
2015
Q3 		– Sell
-3,367
Closed -$76K – 2184
2015
Q2 		$76K Sell
3,367
-5,384
-62% -$122K ﹤0.01% 1882
2015
Q1 		$86K Buy
+8,751
New +$86K ﹤0.01% 2033